Heart Disease News and Research

Latest Heart Disease News and Research

Yissum Research Development signs long-term multi-project collaboration agreement with Roche

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the University, today announced that it has signed a long-term multi-project research and license collaboration agreement with Roche.

23 Oct 2009

Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury

Biotech company Pharming Group NV announced today publication of a preclinical study showing the benefit of using recombinant human C1 inhibitor (rhC1INH) in ischemic brain injury.

23 Oct 2009

Female choice is not connected to "good genes": Study

The great diversity of male sexual traits, ranging from peacock's elaborate train to formidable genitalia of male seed beetles, is the result of female choice. But why do females choose among males? In a new study published today in Current Biology, researchers from Uppsala University found no support for the theory that the female choice is connected to "good genes".

23 Oct 2009

Invatec receives approval to market Mo.Ma device

Invatec, a comprehensive innovator of interventional products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Mo.Ma® Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS).

23 Oct 2009

New Category I CPT code for AspirinWorks Test Kit

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today that a new Category I Current Procedural Terminology (CPT) code has been published by the American Medical Association (AMA) for the AspirinWorks Test Kit.

23 Oct 2009

Canadian Cardiovascular Society to honor University of Alberta medical researcher

A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.

23 Oct 2009

Report: Quality of care for insured Americans slipped in 2008

CNNMoney reports that for the first time in more than 10 years, the "overall quality of health care" for Americans insured through commercial and public plans appears to have slipped.

23 Oct 2009

Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic

Theravance, Inc. announced today that it has earned a milestone payment of $20 million for the U.S. Food and Drug Administration (FDA) approval of VIBATIV (telavancin) and supplying its collaboration partner, Astellas Pharma US, Inc. (Astellas), with the launch inventory for the first commercial sale in the United States.

23 Oct 2009

FDA grants IDE approval to Harvest Technologies to commence its BMAC Enhanced CABG trial

Harvest Technologies Corp. (www.harvesttech.com) announced today that the Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to commence its BMAC Enhanced CABG Trial. This is a two phase 42-patient 'feasibility' clinical trial using the company's BMAC System to concentrate autologous bone marrow cells to treat patients with congestive heart failure undergoing treatment with coronary artery bypass grafting (CABG) Surgery.

22 Oct 2009

Americans split on Obama's health care proposals, new poll finds

Americans are split evenly on President Barack Obama's proposals for health care reform, according to a new poll released Wednesday. Still, a "CNN/Opinion Research Corporation survey indicates that a majority say (sic) it would be better to pass some sort of reform legislation than to leave the current health care system unchanged," CNN reports.

22 Oct 2009

LIVALO statin effective than simvastatin in reducing lipid levels

New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol

22 Oct 2009

Accredo Health Group announces a 10-year renewal of its headquarters with Memphis

Accredo Health Group Inc. announced a 10-year renewal of its 240,000-square-foot headquarters at Century Center, positioning the nation's largest specialty pharmacy and a major fixture of Memphis' health care industry for future growth. The General Investment & Development Companies and Accredo agreed to renew all leases for Accredo's five-building campus, effective January 1, 2010.

22 Oct 2009

KemPharm commences KP106 Phase 1 clinical trial for ADHD

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm’s proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs. KemPharm began the KP106 program in 2007 and has initiated the Phase 1 clinical trial of this candidate in less than 24 months.

22 Oct 2009

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company’s RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.

22 Oct 2009

First-quarter fiscal 2010 results announced by Kensey Nash

Kensey Nash Corporation, a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its first quarter ended September 30, 2009.

22 Oct 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb Company today reported strong sales and earnings growth for the third quarter 2009.

22 Oct 2009

PRINCE study chosen for AHA Scientific Sessions

The first randomized intra-arrest cooling study has been selected for presentation as a Late Breaking trial during the American Heart Association's Scientific Sessions next month.

22 Oct 2009

GeneNews announces the publication of a paper in the Journal of Clinical Gastroenterology

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced the publication of a paper in the Journal of Clinical Gastroenterology. The paper reports data using GeneNews' proprietary Sentinel Principle(R) platform technology to identify complex changes in blood gene expression patterns that were differentially regulated between active and inactive Crohn's disease.

22 Oct 2009

First Edition: October 22, 2009

Some clear themes emerge from today's headlines. Among them: A new government report indicates that health costs grow even faster under Democratic legislation pending in the House; and, yesterday's Senate vote to block the Medicare pay fix bill represents an important loss for Majority Leader Harry Reid.

22 Oct 2009

Peripheral arterial disease linked to lifestyle changes

Modifying the risk of peripheral arterial disease (or PAD)-with healthy lifestyle changes-remains vital to one's health, note researchers in a recent issue of the Journal of Vascular and Interventional Radiology. And while PAD can progress and worsen over time, there is not enough evidence yet to advocate minimally invasive treatment in patients who have had a narrowing or blockage of a leg artery but showing no signs or symptoms of the disease, say Irish researchers in a retrospective study of more than 900 individuals.

22 Oct 2009

Heart Disease News and Research

Latest Heart Disease News and Research

Yissum Research Development signs long-term multi-project collaboration agreement with Roche

Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury

Female choice is not connected to "good genes": Study

Invatec receives approval to market Mo.Ma device

New Category I CPT code for AspirinWorks Test Kit

Canadian Cardiovascular Society to honor University of Alberta medical researcher

Report: Quality of care for insured Americans slipped in 2008

Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic

FDA grants IDE approval to Harvest Technologies to commence its BMAC Enhanced CABG trial

Americans split on Obama's health care proposals, new poll finds

LIVALO statin effective than simvastatin in reducing lipid levels

Accredo Health Group announces a 10-year renewal of its headquarters with Memphis

KemPharm commences KP106 Phase 1 clinical trial for ADHD

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

First-quarter fiscal 2010 results announced by Kensey Nash

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

PRINCE study chosen for AHA Scientific Sessions

GeneNews announces the publication of a paper in the Journal of Clinical Gastroenterology

First Edition: October 22, 2009

Peripheral arterial disease linked to lifestyle changes

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Heart Disease News and Research

Latest Heart Disease News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in